Evaluating group pre-assessment for improving self-efficacy in patients undergoing systemic anticancer therapy
evidence and practice    

Evaluating group pre-assessment for improving self-efficacy in patients undergoing systemic anticancer therapy

Elaine Tomlins Nurse consultant chemotherapy, Royal Marsden NHS Foundation Trust, Sutton, England
Sophie Fisher Trainee advanced nurse practitioner, University Hospital Southampton NHS Foundation Trust, Hampshire, England
Liz Gifford Lead for immunotherapy project, University Hospital Southampton NHS Foundation Trust, Hampshire, England
Amelia Weston Trainee advanced nurse practitioner, University Hospital Southampton NHS Foundation Trust, Hampshire, England

Why you should read this article:
  • To understand the role of patient self-efficacy during systemic anticancer therapy

  • To learn how pre-assessment for patients undergoing systemic anticancer therapy can improve patient self-efficacy

  • To develop ideas for your pre-assessments of patients undergoing systemic anticancer therapy

Maintaining the safety of patients who undergo systemic anticancer therapy (SACT) is a priority and 24-hour acute oncology services have been developed to assist patients in managing treatment-related side effects. Because SACT is mostly delivered in the outpatient setting, healthcare professionals need to be able to rely on patients to recognise and report treatment-related toxicities, which means patients need a high degree of self-efficacy. At University Hospital Southampton NHS Foundation Trust, patients preparing to undergo immunotherapy or chemotherapy take part in a group pre-assessment workshop aimed at improving their self-efficacy.

This article reports the findings of an evaluation of this group pre-assessment workshop. These findings confirm that pre-assessment is a complex intervention that requires adaptability and identifies the need to reiterate information to patients about treatment at every contact with the healthcare team. The group pre-assessment workshop appeared to be acceptable and beneficial to patients but further research is required to determine whether it improves their self-efficacy.

Cancer Nursing Practice. doi: 10.7748/cnp.2021.e1772

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

@Lennae13

Correspondence

elaine.tomlins@rmh.nhs.uk

Conflict of interest

None declared

Tomlins E, Fisher S, Gifford L et al (2021) Evaluating group pre-assessment for improving self-efficacy in patients undergoing systemic anticancer therapy. Cancer Nursing Practice. doi: 10.7748/cnp.2021.e1772

Acknowledgements The authors would like to thank the advanced nurse practitioners who facilitated the group pre-assessment workshops and the patients who completed the survey

Published online: 28 July 2021

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or